Provided By GlobeNewswire
Last update: Feb 21, 2025
REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA.
Read more at globenewswire.comNASDAQ:SEER (7/25/2025, 4:30:02 PM)
2.2
+0.02 (+0.92%)
Find more stocks in the Stock Screener